Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.
Epoch Biodesign has raised $12.0M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.
Epoch Biodesign's investors include Plug and Play, BoxGroup, Lowercarbon Capital, Ascension, Amadeus Capital Partners.
Epoch Biodesign is headquartered in London, United Kingdom.
Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.
Epoch Biodesign is at the Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epoch Biodesign — Funding & Investors." VCBacked, March 25, 2026, https://www.vcbacked.co/company/epoch-biodesign. Accessed July 19, 2026.
VCBacked. (2026). Epoch Biodesign — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/epoch-biodesign
{{cite web |title=Epoch Biodesign — Funding & Investors |url=https://www.vcbacked.co/company/epoch-biodesign |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated